Showing results (631-640 of 833) with videos related to

Sort By:
Pageof 84
The Journal of Pathology|April 20, 2004
Prion protein is ubiquitinated after developing protease resistance in the brains of scrapie-infected miceShin-Chung Kang, David R Brown, Matthew Whiteman, et al.
Neuroscience Letters|January 30, 2002
Hydroxynonenal adducts indicate a role for lipid peroxidation in neocortical and brainstem Lewy bodies in humansRudy J Castellani, George Perry, Sandra L Siedlak, et al.
Annals of the New York Academy of Sciences|July 19, 2005
Estrogen bows to a new master: the role of gonadotropins in Alzheimer pathogenesisKate M Webber, Gemma Casadesus, Michael W Marlatt, et al.
ACS Chemical Neuroscience|April 21, 2015
Curcumin/melatonin hybrid 5-(4-hydroxy-phenyl)-3-oxo-pentanoic acid [2-(5-methoxy-1H-indol-3-yl)-ethyl]-amide ameliorates AD-like pathology in the APP/PS1 mouse modelGorka Gerenu, Kai Liu, Jeremy E Chojnacki, et al.
Antioxidants & Redox Signaling|October 29, 2003
Oxidative stress and neuronal adaptation in Alzheimer disease: the role of SAPK pathwaysXiongwei Zhu, Arun K Raina, Hyoung-Gon Lee, et al.
Neuro-Degenerative Diseases|March 7, 2008
Leucine-rich repeat kinase 2 colocalizes with alpha-synuclein in Parkinson's disease, but not tau-containing deposits in tauopathiesGeorge Perry, Xiongwei Zhu, Asim K Babar, et al.
Bioorganic & Medicinal Chemistry|November 17, 2024
Exploring the rhodanine universe: Design and synthesis of fluorescent rhodanine-based derivatives as anti-fibrillar and anti-oligomer agents against α-synuclein and 2N4R tauAhmed A Elbatrawy, Taiwo A Ademoye, Heba Alnakhala, et al.
ACS Omega|March 3, 2025
Inspecting the Triazole Scaffold as Powerful Antifibril Agents against 2N4R Tau and α-Synuclein AggregatesAhmed A Elbatrawy, Taiwo A Ademoye, Heba Alnakhala, et al.
Neurochemistry International|December 31, 2008
Cell cycle re-entry mediated neurodegeneration and its treatment role in the pathogenesis of Alzheimer's diseaseHyoung-Gon Lee, Gemma Casadesus, Xiongwei Zhu, et al.
Diagnostics (Basel, Switzerland)|July 14, 2023
FDG-PET versus Amyloid-PET Imaging for Diagnosis and Response Evaluation in Alzheimer's Disease: Benefits and PitfallsPoul F Høilund-Carlsen, Mona-Elisabeth Revheim, Tommaso Costa, et al.
Pageof 84